Fig. 3From: Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastasesKaplan–Meier progression-free survival (PFS) curve for MBM patients treated with WBRT (n = 63). Kaplan–Meier curve for MBM patients treated with WBRT (n = 63) shows median PFS of 2.2 months (95% CI 1.7–3), 6-month PFS of 20.4% (95% CI 10.9–32), and 12-month PFS of 3.3% (95% CI 0.3–13.4)Back to article page